NorthSea Therapeutics Funding: $68M Raised, Series C (2020)
NorthSea Therapeutics is based in Naarden, The Netherlands. It has raised $68M in total funding. Latest round: Series C.
NorthSea Therapeutics funding overview
NorthSea Therapeutics is based in Naarden, The Netherlands. NorthSea Therapeutics has raised $68M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2020. The round record for NorthSea Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include venBio Partners, Sofinnova Investments, Forbion, Novo Seeds, New Science Ventures, BioGeneration Ventures. 6 distinct backers are named across the disclosed rounds.
NorthSea Therapeutics at a glance
Total raised
$68M
Latest round
Series C
Latest round date
January 2020
Headquarters
Naarden, The Netherlands
Notable investors
venBio Partners, Sofinnova Investments, Forbion, Novo Seeds, New Science Ventures, BioGeneration Ventures
Frequently asked about NorthSea Therapeutics funding
How much has NorthSea Therapeutics raised?
NorthSea Therapeutics has raised $68M in total disclosed funding across the rounds on record.
Who has invested in NorthSea Therapeutics?
venBio Partners, Sofinnova Investments, Forbion, Novo Seeds, New Science Ventures, BioGeneration Ventures are named among the investors backing NorthSea Therapeutics.
What was the latest NorthSea Therapeutics funding round?
The most recent disclosed round is a Series C, announced in January 2020.
Where is NorthSea Therapeutics based?
NorthSea Therapeutics is based in Naarden, The Netherlands.
When did NorthSea Therapeutics last raise?
The last disclosed NorthSea Therapeutics round closed in January 2020 at Series C.
Every NorthSea Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Naarden at a similar stage.
